TestDynamics Raises $9M to Expand Medical Imaging AI
TestDynamics raised $9M Series A led by Healthier Capital to expand clinical validation and deployment of its medical imaging AI platform.

The big picture: TestDynamics, an Austin, Texas-based developer of artificial intelligence software for medical imaging, has secured $9 million in funding, including a Series A round led by Healthier Capital with participation from Cedars-Sinai Technology Ventures. The company plans to use the capital to expand clinical validation of its medical imaging AI algorithms, increase deployments across hospital systems, and extend its Satori platform into additional imaging subspecialties.
Why it matters:
- AI validation gap: Hospitals adopting medical imaging AI face a growing challenge in determining which algorithms perform reliably across diverse clinical applications and patient populations. A 2024 analysis in Nature Medicine found that 43% of FDA-authorized AI and machine learning medical devices lacked published clinical validation data.
- Vendor neutrality: The proliferation of AI tools from various vendors creates a need for independent evaluation. TestDynamics’ platform offers a vendor-neutral solution, allowing hospitals to assess and coordinate AI algorithms without being locked into a single provider.
- Improving clinical workflows: By continuously benchmarking competing algorithms against validated clinical findings and delivering prioritized results, TestDynamics aims to establish a consistent framework for evaluating AI-generated findings, reducing the burden on radiologists and improving diagnostic confidence.
How it works:
- Integrated evaluation: TestDynamics develops software designed to evaluate, compare, and coordinate AI algorithms used by radiologists. Its Satori platform integrates with existing clinical workflows to provide continuous, objective performance testing.
- Benchmarking and prioritization: Satori continuously benchmarks competing algorithms against validated clinical findings and delivers prioritized results to physicians. This process helps determine which tools are best suited for particular imaging studies.
- Multi-vendor support: The platform combines outputs from multiple AI systems and uses independent performance testing to operate across different vendors, enabling hospitals to evaluate and replace AI algorithms without rebuilding their clinical software infrastructure.
The catch: While the need for independent AI validation is clear, the medical imaging AI market is highly competitive, with numerous startups and established players. TestDynamics will need to demonstrate strong clinical outcomes and seamless integration to gain widespread adoption, especially as hospitals navigate complex procurement processes and existing vendor relationships. The company’s success will depend on its ability to scale deployments and prove its value proposition against the backdrop of rapidly evolving AI capabilities and regulatory scrutiny.
Key Facts
- Company: TestDynamics
- Amount: $9M
- Round: Series A
- Investors: Healthier Capital (lead), Cedars-Sinai Technology Ventures
- Founder: Lior Eshel
- Sector: Medical Imaging AI Validation
- Headquarters: Austin, Texas, US
AIPressRoom Weekly
Every round we reported this week, the people behind the companies, and the events coming up. One email, every Tuesday.